Skip to content
10-Q

Quarterly Report

Neuphoria Therapeutics Inc. NEUP

0001193125-26-054509

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Feb 13, 2026 5.39M sh
Shares Diluted Q2 2025 · Dec 31, 2025 4.54M sh
Shares Diluted Q2 2025 · Dec 31, 2025 3.39M sh
Shares Diluted Q2 2025 · Dec 31, 2024 1.58M sh
Shares Diluted Q2 2025 · Dec 31, 2024 1.44M sh
Operating Cash Flow Q2 2025 · Dec 31, 2025 −$10.23M
Operating Cash Flow Q2 2025 · Dec 31, 2024 −$7.79M
Cash And Equivalents Q2 2025 · Dec 31, 2025 $22.17M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $14.21M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $4.34M
Stockholders Equity Q2 2025 · Dec 31, 2025 $29.7M
Stockholders Equity Q2 2025 · Sep 30, 2025 $12.51M
Stockholders Equity Q2 2025 · Jun 30, 2025 $19M
Stockholders Equity Q2 2025 · Dec 31, 2024 $13.75M
Stockholders Equity Q2 2025 · Sep 30, 2024 $17.07M
Stockholders Equity Q2 2025 · Jun 30, 2024 $17.49M
Current Liabilities Q2 2025 · Dec 31, 2025 $2.59M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.22M
Total Liabilities Q2 2025 · Dec 31, 2025 $6.9M
Total Liabilities Q2 2025 · Jun 30, 2025 $9.59M
Current Assets Q2 2025 · Dec 31, 2025 $23.39M
Current Assets Q2 2025 · Jun 30, 2025 $15.04M
Total Assets Q2 2025 · Dec 31, 2025 $36.6M
Total Assets Q2 2025 · Jun 30, 2025 $28.59M
Eps Diluted Q2 2025 · Dec 31, 2025 −$0.77
Eps Diluted Q2 2025 · Dec 31, 2025 −$2.66
Eps Diluted restated Q2 2025 · Dec 31, 2024 −$1.79
Eps Diluted restated Q2 2025 · Dec 31, 2024 −$4.59
Eps Basic Q2 2025 · Dec 31, 2025 $0.41
Eps Basic Q2 2025 · Dec 31, 2025 −$2.37
Eps Basic Q2 2025 · Dec 31, 2024 −$1.23
Eps Basic Q2 2025 · Dec 31, 2024 −$1.91
Sga Expense Q2 2025 · Dec 31, 2025 $2.13M
Sga Expense Q2 2025 · Dec 31, 2025 $3.99M
Sga Expense Q2 2025 · Dec 31, 2024 $2.63M
Sga Expense Q2 2025 · Dec 31, 2024 $4.3M
Rd Expense Q2 2025 · Dec 31, 2025 $697.72K
Rd Expense Q2 2025 · Dec 31, 2025 $4.48M
Rd Expense Q2 2025 · Dec 31, 2024 $1.74M
Rd Expense Q2 2025 · Dec 31, 2024 $3.64M
Net Income Q2 2025 · Dec 31, 2025 $1.86M
Net Income Q2 2025 · Dec 31, 2025 −$8.04M
Net Income Q2 2025 · Sep 30, 2025 −$9.91M
Net Income Q2 2025 · Dec 31, 2024 −$1.94M
Net Income Q2 2025 · Dec 31, 2024 −$2.75M
Net Income Q2 2025 · Sep 30, 2024 −$804.79K
Operating Income Q2 2025 · Dec 31, 2025 −$4.06M
Operating Income Q2 2025 · Dec 31, 2025 −$9.71M
Operating Income Q2 2025 · Dec 31, 2024 −$3.7M
Operating Income Q2 2025 · Dec 31, 2024 −$7.27M
Revenue Q2 2025 · Dec 31, 2024 $662.72K
Revenue Q2 2025 · Dec 31, 2024 $662.72K